Should clinical trials with concurrent economic analyses be blinded? - Suppr | 超能文献

Should clinical trials with concurrent economic analyses be blinded?

作者信息

Freemantle N, Drummond M

机构信息

Centre for Health Economics, University of York, England.

出版信息

JAMA. 1997 Jan 1;277(1):63-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Should clinical trials with concurrent economic analyses be blinded?

JAMA. 1997 Jan 1;277(1):63-4.

2

Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials.新技术经济评估的分析方法与多中心临床试验的比较

Am Heart J. 2003 Mar;145(3):452-8. doi: 10.1067/mhj.2003.3.

3

Economic benefits of sponsored clinical trials on pharmaceutical expenditures at a medical center in Taiwan.台湾一家医疗中心赞助临床试验对药品支出的经济效益。

Contemp Clin Trials. 2011 Jul;32(4):485-91. doi: 10.1016/j.cct.2011.04.003. Epub 2011 Apr 17.

4

Registering clinical trials is necessary for ethical, scientific and economic reasons.出于伦理、科学和经济方面的原因，对临床试验进行注册是必要的。

Z Arztl Fortbild Qualitatssich. 2004 Aug;98(5):422.

5

Economic analysis alongside clinical trials: practical considerations. The Economics Workgroup.

J Rheumatol. 1995 Jul;22(7):1418-9.

6

Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.将经济分析纳入癌症临床试验：美国国立癌症研究所-美国临床肿瘤学会经济学工作手册

J Natl Cancer Inst Monogr. 1998(24):1-28.

7

Clinical trials: rising costs limit innovation.临床试验：成本上升限制创新。

Ann Neurol. 2007 Dec;62(6):A6-7. doi: 10.1002/ana.21329.

8

Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.在跨国临床试验中开展经济评估：达成研究共识。

Am Heart J. 2005 Mar;149(3):434-43. doi: 10.1016/j.ahj.2004.11.001.

9

Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis.哪些癌症临床试验应被纳入经济评估考量？来自加拿大国家癌症研究所经济分析工作组的选择标准。

Chronic Dis Can. 2003 Fall;24(4):102-7.

10

The cost of clinical trials in cancer.癌症临床试验的成本。

Aust Health Rev. 1982 May;5(2):27-8.

引用本文的文献

1

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia.一项为期一年的精神分裂症患者研究中的运动障碍特征和治疗结果。

Neuropsychiatr Dis Treat. 2013;9:815-22. doi: 10.2147/NDT.S43574. Epub 2013 Jun 14.

2

Insulin degludec improves health-related quality of life (SF-36® ) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials.德谷胰岛素改善 2 型糖尿病患者起始基础胰岛素治疗后的健康相关生活质量（SF-36®），优于甘精胰岛素：3a 期临床试验的荟萃分析。

Diabet Med. 2013 Feb;30(2):226-32. doi: 10.1111/dme.12086.

3

Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate.绝经后妇女服用地舒单抗或阿仑膦酸钠的依从性、偏好和满意度。

Osteoporos Int. 2011 Jun;22(6):1725-35. doi: 10.1007/s00198-010-1378-z. Epub 2010 Sep 9.

4

Real-world trials to answer real-world questions.回答实际问题的真实世界试验。

Pharmacoeconomics. 2005;23(8):747-54. doi: 10.2165/00019053-200523080-00001.

5

A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice.社区药剂师开展的教育推广对英国全科医疗处方影响的随机对照试验。

Br J Gen Pract. 2002 Apr;52(477):290-5.

6

The importance of achieving additional drug benefits at a reasonable cost. A review of the fluoxetine years.

Pharmacoeconomics. 2000 Apr;17(4):319-24. doi: 10.2165/00019053-200017040-00001.

7

Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma.福莫特罗与沙美特罗治疗哮喘患者的成本效益分析。

Pharmacoeconomics. 1998 Dec;14(6):671-84. doi: 10.2165/00019053-199814060-00007.

8

The problem of protocol driven costs in pharmacoeconomic analysis.药物经济学分析中协议驱动成本的问题。

Pharmacoeconomics. 1998 Oct;14(4):357-63. doi: 10.2165/00019053-199814040-00003.

9

Incremental cost-effectiveness ratio of alteplase in patients with acute myocardial infarction in the French setting.法国背景下急性心肌梗死患者使用阿替普酶的增量成本效益比。

Pharmacoeconomics. 1997 Jun;11(6):595-605. doi: 10.2165/00019053-199711060-00007.

10

Decision-analytic valuation of clinical information systems: application to an alerting system for coronary angiography.临床信息系统的决策分析评估：应用于冠状动脉造影警报系统

Proc AMIA Annu Fall Symp. 1997:173-7.